BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38277295)

  • 41. Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study.
    Ramos Bernardes da Silva Filho S; Oliveira Barbosa JH; Rondinoni C; Dos Santos AC; Garrido Salmon CE; da Costa Lima NK; Ferriolli E; Moriguti JC
    Neuroimage Clin; 2017; 15():15-24. PubMed ID: 28459000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Innate Immune Cell Death in Neuroinflammation and Alzheimer's Disease.
    Rajesh Y; Kanneganti TD
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Betaine Mitigates Amyloid-β-Associated Neuroinflammation by Suppressing the NLRP3 and NF-κB Signaling Pathways in Microglial Cells.
    Zhang Y; Jia J
    J Alzheimers Dis; 2023; 94(s1):S9-S19. PubMed ID: 37334594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Focal-type, but not Diffuse-type, Amyloid Beta Plaques are Correlated with Alzheimer's Neuropathology, Cognitive Dysfunction, and Neuroinflammation in the Human Hippocampus.
    Liu F; Sun J; Wang X; Jin S; Sun F; Wang T; Yuan B; Qiu W; Ma C
    Neurosci Bull; 2022 Oct; 38(10):1125-1138. PubMed ID: 36028642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enrichment of infection-associated bacteria in the low biomass brain bacteriota of Alzheimer's disease patients.
    Ko YK; Kim E; Lee EJ; Nam SJ; Kim Y; Kim S; Choi SY; Kim HY; Choi Y
    PLoS One; 2024; 19(2):e0296307. PubMed ID: 38335187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LATE-NC aggravates GVD-mediated necroptosis in Alzheimer's disease.
    Koper MJ; Tomé SO; Gawor K; Belet A; Van Schoor E; Schaeverbeke J; Vandenberghe R; Vandenbulcke M; Ghebremedhin E; Otto M; von Arnim CAF; Balusu S; Blaschko MB; De Strooper B; Thal DR
    Acta Neuropathol Commun; 2022 Sep; 10(1):128. PubMed ID: 36057624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural correlates of cognitive deficits in a selected group of patients with Alzheimer's disease.
    Caramelli P; Robitaille Y; Laroche-Cholette A; Nitrini R; Gauvreau D; Joanette Y; Lecours AR
    Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):184-90. PubMed ID: 9845409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Structural and functional neuronal connectivity in Alzheimer's disease: a combined DTI and fMRI study].
    Soldner J; Meindl T; Koch W; Bokde AL; Reiser MF; Möller HJ; Bürger K; Hampel H; Teipel SJ
    Nervenarzt; 2012 Jul; 83(7):878-87. PubMed ID: 21713583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer's disease.
    Dong Y; Yu H; Li X; Bian K; Zheng Y; Dai M; Feng X; Sun Y; He Y; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
    J Neuroinflammation; 2022 Aug; 19(1):205. PubMed ID: 35971179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease.
    Hampel H; Caraci F; Cuello AC; Caruso G; Nisticò R; Corbo M; Baldacci F; Toschi N; Garaci F; Chiesa PA; Verdooner SR; Akman-Anderson L; Hernández F; Ávila J; Emanuele E; Valenzuela PL; Lucía A; Watling M; Imbimbo BP; Vergallo A; Lista S
    Front Immunol; 2020; 11():456. PubMed ID: 32296418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Qi Fu Yin ameliorates neuroinflammation through inhibiting RAGE and TLR4/NF-κB pathway in AD model rats.
    He C; Yu W; Yang M; Li Z; Yu J; Zhong D; Deng S; Song Z; Cheng S
    Aging (Albany NY); 2023 Nov; 15(22):13239-13264. PubMed ID: 38006400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer's Disease and Involvement of Neuroinflammation.
    Liu D; Zhao D; Zhao Y; Wang Y; Zhao Y; Wen C
    Curr Alzheimer Res; 2019; 16(6):473-482. PubMed ID: 31456514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease.
    Grammas P; Ovase R
    Neurobiol Aging; 2001; 22(6):837-42. PubMed ID: 11754990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices.
    Wang H; Shen Y; Chuang H; Chiu C; Ye Y; Zhao L
    Curr Alzheimer Res; 2019; 16(7):659-674. PubMed ID: 31580243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tetrahydroxy stilbene glycoside ameliorates neuroinflammation for Alzheimer's disease via cGAS-STING.
    Gao D; Hao JP; Li BY; Zheng CC; Miao BB; Zhang L; Li YL; Li L; Li XJ; Zhang L
    Eur J Pharmacol; 2023 Aug; 953():175809. PubMed ID: 37328043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LiuweiDihuang improved cognitive functions in SAMP8 mice by inhibiting COX-2 expression and subsequent neuroinflammation.
    Song J; Jia Y; Li J; Ding R; Yuan Y; Cai J; Su Y; Hua Q; Zhang Z
    J Ethnopharmacol; 2022 Oct; 296():115491. PubMed ID: 35752263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
    Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH
    J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer's Brain Tissue.
    Ni R; Röjdner J; Voytenko L; Dyrks T; Thiele A; Marutle A; Nordberg A
    J Alzheimers Dis; 2021; 80(4):1723-1737. PubMed ID: 33749648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3
    Yang W; Liu Y; Xu QQ; Xian YF; Lin ZX
    Oxid Med Cell Longev; 2020; 2020():4754195. PubMed ID: 32963694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
    Lanzrein AS; Johnston CM; Perry VH; Jobst KA; King EM; Smith AD
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):215-27. PubMed ID: 9772027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.